Sep 05 2024 30 mins 2
In this podcast episode, we sit down with Christopher Heery, the Chief Medical Officer at Arcellx to learn about the company's pipeline and lead cell therapy, anitocabtagene autoleucel, or anito-cel, that is in development for multiple myeloma.
Multiple myeloma, like lymphoma and leukemia are types of cancer that start in your blood cells.
Multiple myeloma, like lymphoma and leukemia are types of cancer that start in your blood cells.
